Background: Endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA) is the preferred modality for sampling intrathoracic lymph nodes in patients with suspected sarcoidosis. Whether the number of revolutions of the needle inside the lymph node while performing TBNA affects the diagnostic yield is unknown. Objectives: The aim of this paper was to compare the yield of different numbers of needle revolutions (10 vs. 20) during EBUS-TBNA in sarcoidosis. Methods: Consecutive subjects with a clinicoradiological suspicion of sarcoidosis were randomized 1: 1 to undergo EBUS-TBNA with either 10 (group 1) or 20 revolutions (group 2). The primary and secondary outcomes were the diagnostic yield and adequacy of aspirates, respectively. Other outcomes were procedure duration, gross blood contamination of the aspirates, and safety of the procedure. Results: Of the 171 subjects screened, 150 (mean age 43.5 years; 47.3% women) were randomized. A mean of 2.8 (group 1: 2.8, group 2: 2.7; p = 0.37) lymph nodes were sampled per subject with a mean of 2.1 passes per node in each group (p = 0.60). Among 133 subjects finally diagnosed with sarcoidosis, there was no difference (p = 0.65) in the diagnostic yield of EBUS-TBNA between group 1 (52/65, 80.0%) and group 2 (57/68, 83.8%). Adequate aspirates were obtained in 96.9 and 97.1% of the subjects in groups 1 and 2, respectively (p = 1.00). There was no difference in the procedure duration, the proportion of subjects with grossly bloody specimens, or complications between the 2 groups. Conclusions: The diagnostic yield and specimen adequacy were not different when EBUS-TBNA was performed with 10 or 20 revolutions in subjects with sarcoidosis.

1.
Baughman RP, Culver DA, Judson MA: A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 2011; 183: 573–581.
2.
Tremblay A, Stather DR, Maceachern P, Khalil M, Field SK: A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest 2009; 136: 340–346.
3.
Navani N, Lawrence DR, Kolvekar S, Hayward M, McAsey D, Kocjan G, Falzon M, Capitanio A, Shaw P, Morris S, Omar RZ, Janes SM: Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial. Am J Respir Crit Care Med 2012; 186: 255–260.
4.
von Bartheld MB, Dekkers OM, Szlubowski A, Eberhardt R, Herth FJ, in’t Veen JC, de Jong YP, van der Heijden EH, Tournoy KG, Claussen M, van den Blink B, Shah PL, Zoumot Z, Clementsen P, Porsbjerg C, Mauad T, Bernardi FD, van Zwet EW, Rabe KF, Annema JT: Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA 2013; 309: 2457–2464.
5.
von Bartheld MB, van Breda A, Annema JT: Complication rate of endosonography (endobronchial and endoscopic ultrasound): a systematic review. Respiration 2014; 87: 343–351.
6.
Agarwal R, Srinivasan A, Aggarwal AN, Gupta D: Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Med 2012; 106: 883–892.
7.
Gupta D, Dadhwal DS, Agarwal R, Gupta N, Bal A, Aggarwal AN: Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis. Chest 2014; 146: 547–556.
8.
Muthu V, Gupta N, Dhooria S, Sehgal IS, Bal A, Aggarwal AN, Behera D, Agarwal R: A prospective, randomized, double-blind trial comparing the diagnostic yield of 21- and 22-gauge aspiration needles for performing endobronchial ultrasound-guided transbronchial needle aspiration in sarcoidosis. Chest 2016; 149: 1111–1113.
9.
Madan K, Dhungana A, Mohan A, Hadda V, Jain D, Arava S, Pandey RM, Khilnani GC, Guleria R: Conventional transbronchial needle aspiration versus endobronchial ultrasound-guided transbronchial needle aspiration, with or without rapid on-site evaluation, for the diagnosis of sarcoidosis: a randomized controlled trial. J Bronchology Interv Pulmonol 2017; 24: 48–58.
10.
Hu LX, Chen RX, Huang H, Shao C, Wang P, Liu YZ, Xu ZJ: Endobronchial ultrasound-guided transbronchial needle aspiration versus standard bronchoscopic modalities for diagnosis of sarcoidosis: a meta-analysis. Chin Med J (Engl) 2016; 129: 1607–1615.
11.
Sun J, Yang H, Teng J, Zhang J, Zhao H, Garfield DH, Han B: Determining factors in diagnosing pulmonary sarcoidosis by endobronchial ultrasound-guided transbronchial needle aspiration. Ann Thorac Surg 2015; 99: 441–445.
12.
Biswas A, Wynne JP, Patel D, Weber M, Thakur S, Sriram PS: Comparison of the yield of 19-G eXcelon core needle to a 21-G EBUS needle during endobronchial ultrasound guided transbronchial needle aspiration of mediastinal lymph nodes for the detection of granulomas in cases of suspected sarcoidosis. J Thorac Dis 2017; 9:E864–E866.
13.
Oki M, Saka H, Ando M, Nakashima H, Shiraki A, Murakami Y, Kogure Y, Kitagawa C, Kato T: How many passes are needed for endobronchial ultrasound-guided transbronchial needle aspiration for sarcoidosis? A prospective multicenter study. Respiration 2018; 95: 251–257.
14.
van der Heijden EH, Casal RF, Trisolini R, Steinfort DP, Hwangbo B, Nakajima T, Guldhammer-Skov B, Rossi G, Ferretti M, Herth FF, Yung R, Krasnik M: Guideline for the acquisition and preparation of conventional and endobronchial ultrasound-guided transbronchial needle aspiration specimens for the diagnosis and molecular testing of patients with known or suspected lung cancer. Respiration 2014; 88: 500–517.
15.
Wahidi MM, Herth F, Yasufuku K, Shepherd RW, Yarmus L, Chawla M, Lamb C, Casey KR, Patel S, Silvestri GA, Feller-Kopman DJ: Technical aspects of endobronchial ultrasound-guided transbronchial needle aspiration: CHEST guideline and expert panel report. Chest 2016; 149: 816–835.
16.
Casal RF, Staerkel GA, Ost D, Almeida FA, Uzbeck MH, Eapen GA, Jimenez CA, Nogueras-Gonzalez GM, Sarkiss M, Morice RC: Randomized clinical trial of endobronchial ultrasound needle biopsy with and without aspiration. Chest 2012; 142: 568–573.
17.
Kaur H, Dhooria S, Aggarwal AN, Gupta D, Behera D, Agarwal R: A Randomized trial of 1 versus 2% lignocaine by the spray-as-you-go technique for topical anesthesia during flexible bronchoscopy. Chest 2015; 148: 739–745.
18.
Dhooria S, Sehgal IS, Gupta N, Aggarwal AN, Behera D, Agarwal R: Diagnostic yield and complications of EBUS-TBNA performed under bronchoscopist-directed conscious sedation: single center experience of 1004 subjects. J Bronchology Interv Pul-monol 2017; 24: 7–14.
19.
Dhooria S, Agarwal R, Aggarwal AN, Bal A, Gupta N, Gupta D: Differentiating tuberculosis from sarcoidosis by sonographic characteristics of lymph nodes on endobronchial ultrasonography: a study of 165 patients. J Thorac Cardiovasc Surg 2014; 148: 662–667.
20.
Dhooria S, Agarwal R, Aggarwal AN, Gupta N, Gupta D, Behera D: Agreement of mediastinal lymph node size between computed tomography and endobronchial ultrasonography: a study of 617 patients. Ann Thorac Surg 2015; 99: 1894–1898.
21.
Sehgal IS, Bal A, Dhooria S, Agrawal P, Gupta N, Ram B, Aggarwal AN, Behera D, Agarwal R: A prospective randomized controlled trial comparing the efficacy and safety of cup vs alligator forceps for performing transbronchial lung biopsy in patients with sarcoidosis. Chest 2016; 149: 1584–1586.
22.
Dhooria S, Gupta N, Bal A, Sehgal IS, Aggarwal AN, Sethi S, Behera D, Agarwal R: Role of Xpert MTB/RIF in differentiating tuberculosis from sarcoidosis in patients with mediastinal lymphadenopathy undergoing EBUS-TBNA: a study of 147 patients. Sarcoidosis Vasc Diffuse Lung Dis 2016; 33: 258–266.
23.
Costabel U, Hunninghake GW: ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999; 14: 735–737.
24.
Statement on sarcoidosis: Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736–755.
25.
Dhooria S, Sehgal IS, Aggarwal AN, Agarwal R: Convex-probe endobronchial ultrasound: a decade of progress. Indian J Chest Dis Allied Sci 2016; 58: 21–35.
26.
Murgu SD: Diagnosing and staging lung cancer involving the mediastinum. Chest 2015; 147: 1401–1412.
27.
Amin EN, Russell CD, Shilo K, Islam S, Wood KL: Diagnostic value of blood clot core during endobronchial ultrasound-guided transbronchial needle aspirate. Lung 2013; 191: 305–309.
28.
Gupta D, Agarwal R, Aggarwal AN, Jindal SK: Sarcoidosis and tuberculosis: the same disease with different manifestations or similar manifestations of different disorders. Curr Opin Pulm Med 2012; 18: 506–516.
29.
Scholten EL, Semaan R, Illei P, Mallow C, Arias S, Feller-Kopman D, Oakjones-Burgess K, Frimpong B, Ortiz R, Lee H, Yarmus L: Stylet use does not improve diagnostic outcomes in endobronchial ultrasonographic transbronchial needle aspiration: a randomized clinical trial. Chest 2017; 151: 636–642.
30.
Tyan C, Patel P, Czarnecka K, Gompelmann D, Eberhardt R, Fortin M, MacEachern P, Hergott CA, Dumoulin E, Tremblay A, Kemp SV, Shah PL, Herth FJF, Yasufuku K: Flexible 19-gauge endobronchial ultrasound-guided transbronchial needle aspiration needle: first experience. Respiration 2017; 94: 52–57.
31.
Czarnecka-Kujawa K, Tremblay A, Yasufuku K, Sczaniecka A, Parthiban S, Kunz L, Dillard D, Gonzalez X: A preclinical evaluation comparing the performance of a novel 19-G flexible needle to a commercially available 22-G EBUS-TBNA sampling needle. Respiration 2018; 95: 55–62.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.